Follow the JW신약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, JW신약 has logged 24 insider filings. Market capitalisation: €73.9bn. The latest transaction was filed on 5 March 2026 (Other). Among the most active insiders: JW홀딩스. The full history is free.
24
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,069 of 26,211 companies
80.2
score / 100
Value
80
Quality
81
FCF yld4.3%
Earn yld15%
EV/EBITDA6.4x
ROE·
Gross mgn50%
Net mgn19%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.